Evaluation of an App Based on Artificial Intelligence for Pain Assessment in Pediatric Department
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Sep 1, 2022
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
Acute pain is the reason that the majority of patients present to the Emergency Department. Multiple studies conducted over many years have demonstrated that pain is poorly managed in the Emergency Department. This phenomenon has been referred to in the Medical Literature as "Oligoanalgesia.". Morever, untreated pain can have short and long term effects in Pediatric population, including sensitisation to pain episodes in later life and can affects the Neurodevelopment of the child.
The generally accepted standard for pain assessment is self-reported; however, in preverbal children who cann...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Child under 18
- • Informed and written consent of a parent or guardian (only 1 accompanying person allowed).
- Exclusion Criteria:
- • Language barrier.
- • Refusal to participate by parents/children
- • Sign of collapsus, or in serious clinical condition (stage I or II) requiring absolute emergency care,
- • Delayed mental or staturo-ponderal development
- • Facial injury or wound, presence of a bandage on the face, pre-existing facial deformity
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, Chu De Nice, France
Nice, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials